Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: The Hidden Epidemic

被引:20
作者
Ismail, Mona H. [1 ]
机构
[1] Univ Dammam, King Fahad Hosp, Coll Med, Dept Internal Med,Div Gastroenterol, Al Khobar 31952, Saudi Arabia
关键词
Nonalcoholic fatty liver disease; Type; 2; diabetes; Nonalcoholic steatohepatitis; NAFLD diagnosis; LIFE-STYLE MODIFICATION; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; BARIATRIC SURGERY; WEIGHT-LOSS; AMINOTRANSFERASE LEVELS; PHYSICAL-ACTIVITY; NATURAL-HISTORY; SERUM MARKER;
D O I
10.1097/MAJ.0b013e3182018598
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized cause of liver disease worldwide. With obesity being a universally important risk factor, NAFLD is now receiving greater attention as a public health issue, and the burden of NAFLD is expected to increase in years to come. The prevalence of NAFLD among subjects with diabetes and with severe obesity is on the rise around the world, including in Saudi Arabia. Efforts in developing new strategies for its prevention, diagnosis and management are needed to alter the course of this disease. The purpose of this review is to enhance awareness about the close interrelationship between NAFLD and type 2 diabetes mellitus and recent diagnostic and treatment advances in the field.
引用
收藏
页码:485 / 492
页数:8
相关论文
共 69 条
[1]   The natural history of nonalcoholic fatty liver disease: A population-based cohort study [J].
Adams, LA ;
Lymp, JF ;
St Sauver, J ;
Sanderson, SO ;
Lindor, KD ;
Feldstein, A ;
Angulo, P .
GASTROENTEROLOGY, 2005, 129 (01) :113-121
[2]   Nonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort Study [J].
Adams, Leon A. ;
Harmsen, Scott ;
St Sauver, Jennifer L. ;
Charatcharoenwitthaya, Phunchai ;
Enders, Felicity B. ;
Therneau, Terry ;
Angulo, Paul .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (07) :1567-1573
[3]  
ALQUORAIN A, 1994, TROP GEOGR MED, V46, P358
[4]   GI Epidemiology: nonalcoholic fatty liver disease [J].
Angulo, P. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (08) :883-889
[5]   Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis [J].
Angulo, P ;
Keach, JC ;
Batts, KP ;
Lindor, KD .
HEPATOLOGY, 1999, 30 (06) :1356-1362
[6]   The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD [J].
Angulo, Paul ;
Hui, Jason M. ;
Marchesini, Giulio ;
Bugianesi, Ellisabetta ;
George, Jacob ;
Farrell, Geoffrey C. ;
Enders, Felicity ;
Saksena, Sushma ;
Burt, Alastair D. ;
Bida, John P. ;
Lindor, Keith ;
Sanderson, Schuyler O. ;
Lenzi, Marco ;
Adams, Leon A. ;
Kench, James ;
Therneau, Terry M. ;
Day, Christopher P. .
HEPATOLOGY, 2007, 45 (04) :846-854
[7]  
[Anonymous], J BIOL CHEM
[8]   Non-alcoholic steatohepatitis: Effect of Roux-en-Y gastric bypass surgery [J].
Barker, KB ;
Palekar, NA ;
Bowers, SP ;
Goldberg, JE ;
Pulcini, JP ;
Harrison, SA .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (02) :368-373
[9]   Sampling variability of liver fibrosis in chronic hepatitis C [J].
Bedossa, P ;
Dargère, D ;
Paradis, V .
HEPATOLOGY, 2003, 38 (06) :1449-1457
[10]   A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis [J].
Belfort, Renata ;
Harrison, Stephen A. ;
Brown, Kenneth ;
Darland, Celia ;
Finch, Joan ;
Hardies, Jean ;
Balas, Bogdan ;
Gastaldelli, Amalia ;
Tio, Fermin ;
Pulcini, Joseph ;
Berria, Rachele ;
Ma, Jennie Z. ;
Dwivedi, Sunil ;
Havranek, Russell ;
Fincke, Chris ;
DeFronzo, Ralph ;
Bannayan, George A. ;
Schenker, Steven ;
Cusi, Kenneth .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (22) :2297-2307